Citations

Showing 10 of 108104 citations.

The Selinexor in Advanced Liposarcoma (SEAL) study: A phase 2/3, multicenter, randomized, double blind study of selinexor versus placebo in patients with advanced, unresectable, dedifferentiated liposarcoma (DDLS).
Gounder, Mrinal M. , Wagner, Andrew J. , Somaiah, Neeta , Riedel, Richard F. , Attia, Steven , Razak, Albiruni R. Abdul, Cranmer, Lee D. , Okuno, Scott H. , Choe-Juliak, Cassandra, Shacham, Sharon, Kauffman, Michael , Chawla, Sant P. , Riedel, Richard F , Schwartz, Gary K. , Milhem, Mohammed

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: TPS11072-TPS11072

10.1200/jco.2016.34.15_suppl.tps11072 Get It

Patterns of palliative care utilization and end of life care in adult patients with cancer who died as inpatients at Mayo Clinic.
Zimmerman, Collin, Shinde, Shivani, Litzow, Mark R. , Kasi, Pashtoon Murtaza , Huddleston, Jeanne M.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: e21681-e21681

10.1200/jco.2016.34.15_suppl.e21681 Get It

Outcomes of extraskeletal osteosarcoma patients and role of perioperative chemotherapy.
Fritchie, Karen , Rose, Peter S. , Arndt, Carola A.S., Okuno, Scott H. , Paludo, Jonas , Haddox, Candace L. , Robinson, Steven I.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 11025-11025

10.1200/jco.2016.34.15_suppl.11025 Get It

Safety and efficacy of PD-1 blockade using pembrolizumab in patients with advanced soft tissue (STS) and bone sarcomas (BS): Results of SARC028—A multicenter phase II study.
Tawbi, Hussein, Crowley, John, Tine, Brian Andrew Van, Hu, James , Schuetze, Scott M. , Attia, Steven , Priebat, Dennis A., Okuno, Scott H. , Riedel, Richard F. , Movva, Sujana , Baker, Laurence H. , Maki, Robert G. , Patel, Shreyaskumar , Investigators, for SARC028, Maki, Robert G , Riedel, Richard F , Burgess, Melissa , D'Angelo, Sandra P , Davis, Lara E. , Reed, Damon R. , Reinke, Denise K. , Investigators, for SARC028

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 11006-11006

10.1200/jco.2016.34.15_suppl.11006 Get It

ADVL1315: A phase 1 study of the VEGF receptor tyrosine kinase inhibitor axitinib (INLYTA, IND# 123101) in children with recurrent or refractory solid tumors—A Children's Oncology Group study.
Fox, Elizabeth , Turpin, Brian , Liu, Xiaowei , Goldstein, Stuart, Weigel, Brenda J. , Geller, James I. , Reid, Joel M. , Minard, Charles G.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 10558-10558

10.1200/jco.2016.34.15_suppl.10558 Get It

Prognostic value of tumor response in pediatric and adult patients with Ewing sarcoma.
Chihak, Melanie A., Keeney, Michael, Fritchie, Karen , Harmsen, William S. , Arndt, Carola A.S., Ruddy, Kathryn J. , Ahmed, Safia K. , Laack, Nadia N.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 10543-10543

10.1200/jco.2016.34.15_suppl.10543 Get It

Longitudinal changes in patient-reported symptoms and physical function during taxane-based chemotherapy in breast cancer patients.
Monfort, Scott M. , Pan, Xueliang , Patrick, Robyn , Singaravelu, Janani, Mrózek, Ewa, Ramaswamy, Bhuvaneswari , Reinbolt, Raquel E. , Naughton, Michelle J. , Loprinzi, Charles L. , Chaudhari, Ajit M.W. , Layman, Rachel M. , Wesolowski, Robert , Shapiro, Charles L. , Lustberg, Maryam B.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 10098-10098

10.1200/jco.2016.34.15_suppl.10098 Get It

Efficacy of immunotherapy in advanced melanoma: A network meta-analysis.
Firwana, Belal , Makhoul, Issam , Hutchins, Laura F. , Mahmoud, Fade , Sonbol, Mohamad Bassam , Atrash, Shebli , Murad, M. Hassan

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: e21033-e21033

10.1200/jco.2016.34.15_suppl.e21033 Get It

The Mayo Clinic experience in patients with metastatic melanoma who have failed previous pembrolizumab treatment.
Yan, Yiyi , Failing, Jarrett, Leontovich, Alexey A. , Block, Matthew S. , Kottschade, Lisa A. , Dronca, Roxana , Markovic, Svetomir, McWilliams, Robert R. , Markovic, Svetomir N.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: e21014-e21014

10.1200/jco.2016.34.15_suppl.e21014 Get It

Benefit of chemotherapy (CT) in patients (pts) with Merkel cell carcinoma (MCC) with distant metastases (mets) and visceral organ involvement.
Sabol, Angeline J., Otley, Clark C. , Price, Katharine A. , Markovic, Svetomir N.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: e21000-e21000

10.1200/jco.2016.34.15_suppl.e21000 Get It